The role of somatosensory innervation of adipose tissues Y Wang, VH Leung, Y Zhang, VS Nudell, M Loud, MR Servin-Vences, ... Nature 609 (7927), 569-574, 2022 | 35 | 2022 |
Organism-wide, cell-type-specific secretome mapping of exercise training in mice W Wei, NM Riley, X Lyu, X Shen, J Guo, SH Raun, M Zhao, ... Cell Metabolism 35 (7), 1261-1279. e11, 2023 | 20 | 2023 |
Salicylic acid derivatives inhibit oxalate production in mouse hepatocytes with primary hyperoxaluria type 1 MD Moya-Garzón, C Martin Higueras, P Peñalver, M Romera, ... Journal of Medicinal Chemistry 61 (16), 7144-7167, 2018 | 20 | 2018 |
Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias MD Moya-Garzon, JA Gomez-Vidal, A Alejo-Armijo, J Altarejos, ... Journal of Personalized Medicine 11 (2), 74, 2021 | 19 | 2021 |
Development of a Cannabinoid-Based Photoaffinity Probe to Determine the Δ8/9-Tetrahydrocannabinol Protein Interaction Landscape in Neuroblastoma Cells M Soethoudt, G Alachouzos, EJ van Rooden, MD Moya-Garzón, ... Cannabis and Cannabinoid Research 3 (1), 136-151, 2018 | 11 | 2018 |
Structural insights into the mechanism of leptin receptor activation RA Saxton, NA Caveney, MD Moya-Garzon, KD Householder, ... Nature Communications 14 (1), 1797, 2023 | 9 | 2023 |
New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production MD Moya-Garzon, B Rodriguez-Rodriguez, C Martin-Higueras, ... European Journal of Medicinal Chemistry 237, 114396, 2022 | 8 | 2022 |
Binding and sequestration of poison frog alkaloids by a plasma globulin A Alvarez-Buylla, MT Fischer, MDM Garzon, AE Rangel, EE Tapia, ... Elife 12, e85096, 2023 | 4 | 2023 |
CYP4F2 is a human-specific determinant of circulating N-acyl amino acid levels JT Tanzo, VL Li, AL Wiggenhorn, MD Moya-Garzon, W Wei, X Lyu, ... Journal of Biological Chemistry 299 (6), 2023 | 2 | 2023 |
Organism-wide secretome mapping uncovers pathways of tissue crosstalk in exercise W Wei, NM Riley, X Lyu, X Shen, J Guo, M Zhao, MD Moya-Garzon, ... bioRxiv, 2022.11. 21.517385, 2022 | 1 | 2022 |
Compounds for the treatment of diseases caused by oxalate accumulation MD GAVILAN, JAG Vidal, MDM GARZON, ES RUIZ, CM HIGUERAS, ... US Patent App. 16/492,750, 2020 | | 2020 |
V GEQB ChemBio JC Morales, S Martín-Santamaría, A Conejo | | 2020 |
Síntesis de nuevos compuestos inhibidores de glicolato oxidasa. Aplicación en hiperoxaluria primaria y evaluación biológica MD Moya Garzón Universidad de Granada, 2019 | | 2019 |
Compuestos para el tratamiento de enfermedades causadas por la acumulación de oxalato M Díaz Gavilán, JA Gómez Vidal, MD Moya Garzón, E Salido Ruiz, ... Oficina Española de Patentes y Marcas, 2018 | | 2018 |
New glycolate oxidase inhibitors as promising drugs for primary hyperoxaluria type 1 C Martin-Higueras, MD Moya-Garzon, JA Gomez-Vidal, M Diaz-Gavilan, ... PEDIATRIC NEPHROLOGY 31 (10), 1892-1892, 2016 | | 2016 |